Journal
/
Investigación sobre el cáncer
/
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
JoVE Revista
Investigación sobre el cáncer
This content is Free Access.
JoVE Revista Investigación sobre el cáncer
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

DOI:
10.3791/57011-v

•

07:18 min

•

June 13, 2019

•

, , , ,
1Department of Pathology,Icahn School of Medicine at Mount Sinai

Capítulos

  • 00:04Título
  • 00:44Sarcoma Tissue Sample Processing and Patient-derived Xenograft (PDX) Formation
  • 02:32Tumor-initiating Cell (TIC) Sorting and Sarcosphere Formation
  • 05:11Results: Representative Human Leukocyte Antigen (HLA)-1-Negative TIC Characterization
  • 06:42Conclusion

Summary

Traducción Automática

Traducción Automática

We describe a detailed protocol for the isolation of tumor-initiating cells from human sarcoma patient-derived xenografts by fluorescence-activated cell sorting, using human leukocyte antigen-1 (HLA-1) as a negative marker, and for the further validation and characterization of these HLA-1-negative tumor-initiating cells.

Tags

Tumor-initiating CellsSarcomaPatient-derived XenograftsHLA-IEpigenetic DownregulationCancer Stem CellsImmune EscapeSingle Cell SuspensionNOD Scid Gamma MouseBasement Membrane MatrixHistological Analysis

Article

Embed

Añadir a la lista de reproducción

Usage Statistics

Videos relacionados

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

A Melanoma Patient-Derived Xenograft Model

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Enhanced Viability for Ex vivo 3D Hydrogel Cultures of Patient-Derived Xenografts in a Perfused Microfluidic Platform

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

Read Article